AstraZeneca CEO £2.3m Bonus Hike Sparks Shareholder Row - Yahoo! Finance -BoardProspects

AstraZeneca CEO £2.3m Bonus Hike Sparks Shareholder Row

Yahoo! Finance May 9 2021 BoardNews

Pascal Soriot, as AstraZeneca Executive Director and CEO, during US Senate Finance Committee hearing on drug prices, graphic element on gray Amid mounting scrutiny of AstraZeneca's ( AZ.L ) COVID-19 vaccine, the company's CEO is facing pushback from shareholders over a potential big bump in bonuses. Pascal Soriot is in line for a windfall of between £2.3m ($3.2m) and £12m — a sum that could rise in line with AstraZeneca's share price...
Read Full Article

Bookmark or Share this article

Login to comment.
Related Articles
- Still few women on boards also categorized in BoardNews
- Transocean chairman Talbert to retire also published in Yahoo! Finance
- TA Associates announces investment in Flashtalking also mentions Investment
- Tensions with the Board Not the Norm, Say 98 Percent of CEOs also categorized in BoardNews
- Corporate Governance Best Practices also categorized in BoardNews
- NACD BoardVision - NACD BoardVision – “The role of the board as company spokesperson” - Resources - NACD also categorized in BoardNews
- Boardmember.com's 10 Most Viewed Articles of 2011 also categorized in BoardNews
- The Horace Mann Companies on Forbes Top 100 Trustworthy Companies in America also published in Yahoo! Finance
- Corporate Boards: Shifting From Aging Men To New Generation Of Women? also categorized in BoardNews
- Executive Compensation: What Will 2012 Bring? — The Harvard Law School Forum on Corporate Governance and Financial Regulation also categorized in BoardNews

Search:
Categories
1. BoardProspects Features:
  Board Recruitment Publication, BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
Topics Mentioned
- Management
- COVID
- Investment
- COVID-19
- Coronavirus
- Investors
- ISS
- Institutional Shareholder Services
- Glass Lewis
- AstraZeneca
- Aviva
- Shareholder
- UK
- Pascal Soriot
- activist investor
- CEO
- 3M
- Bonus
- Bonuses
- Covid-19 vaccine